Biosimilars for IBD: Making the Transition
May 28 @ 7:00 pm - 8:00 pm
Join CDHF, and Dr. Jeffrey McCurdy May 28th at 7pm EST to chat all things Biosimilars for IBD.
The webinar will answer the following questions:
• What’s the difference between a reference biologic drug and a biosimilar?
• Biosimilars: What’s Health Canada saying?
• What is the clinical evidence to date?
• How do doctors go about doctors transitioning their patients from a reference biologic drug to a biosimilar?
We will also hear from two patients who have successfully transitioned from a reference biologic drug to a biosimilar.
Q&A period will follow – so come with your questions!
You must register to view the webinar at: https://cdhf.ca/events/